Li Li1, Jia Ji, Jian-Bing Wang, Mayineur Niyazi, You-Lin Qiao, Paolo Boffetta. 1. Department of Gynecology, the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830011, China ; Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Abstract
OBJECTIVE: To provide an evidence-based, consistent assessment of the burden of breast cancer attributable to reproductive factors (RFs, including nulliparity, mean number of children, age at first birth and breastfeeding), use of oral contraceptives (OCs, restricted to the age group of 15-49 years), and hormone replacement therapy (HRT), as well as of the burden of ovarian cancer attributable to the mean number of children in China in 2005. METHODS: We derived the prevalence of these risk factors and the relative risk of breast and ovarian cancer from national surveys or large-scale studies conducted in China. In the case of RFs, we compared the exposure distributions in 2001 and counterfactual exposure. RESULTS: Exposure of RFs in 2001 was found to account for 6.74% of breast cancer, corresponding to 9,617 cases and 2,769 deaths, and for 2.78% of ovarian cancer (711 cases, 294 deaths). The decrease in mean number of children alone was responsible for 1.47% of breast cancer and 2.78% of ovarian cancer. The prevalence of OC use was 1.74% and the population attributable fraction (PAF) of breast cancer was 0.71%, corresponding to 310 cases and 90 deaths. The PAF of breast cancer due to HRT was 0.31%, resulting in 297 cases and 85 deaths. CONCLUSION: RFs changes in China contributed to a sizable fraction of breast and ovarian cancer incidence and mortality, whereas HRT and OCs accounted for relatively low incidence of breast cancer in China.
OBJECTIVE: To provide an evidence-based, consistent assessment of the burden of breast cancer attributable to reproductive factors (RFs, including nulliparity, mean number of children, age at first birth and breastfeeding), use of oral contraceptives (OCs, restricted to the age group of 15-49 years), and hormone replacement therapy (HRT), as well as of the burden of ovarian cancer attributable to the mean number of children in China in 2005. METHODS: We derived the prevalence of these risk factors and the relative risk of breast and ovarian cancer from national surveys or large-scale studies conducted in China. In the case of RFs, we compared the exposure distributions in 2001 and counterfactual exposure. RESULTS: Exposure of RFs in 2001 was found to account for 6.74% of breast cancer, corresponding to 9,617 cases and 2,769 deaths, and for 2.78% of ovarian cancer (711 cases, 294 deaths). The decrease in mean number of children alone was responsible for 1.47% of breast cancer and 2.78% of ovarian cancer. The prevalence of OC use was 1.74% and the population attributable fraction (PAF) of breast cancer was 0.71%, corresponding to 310 cases and 90 deaths. The PAF of breast cancer due to HRT was 0.31%, resulting in 297 cases and 85 deaths. CONCLUSION: RFs changes in China contributed to a sizable fraction of breast and ovarian cancer incidence and mortality, whereas HRT and OCs accounted for relatively low incidence of breast cancer in China.
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Chunyuan Wu; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Neilann K Horner; Zakia C Nelson; Johanna W Lampe; Yong Wei Hu; Jackilen Shannon; Helge Stalsberg; Wenjin Li; Dawn Fitzgibbons; Peggy Porter; Ruth E Patterson; Jessie A Satia; David B Thomas Journal: Am J Epidemiol Date: 2004-11-15 Impact factor: 4.897
Authors: Fariba Salehi; Lesley Dunfield; Karen P Phillips; Daniel Krewski; Barbara C Vanderhyden Journal: J Toxicol Environ Health B Crit Rev Date: 2008-03 Impact factor: 6.393
Authors: J B Wang; Y Jiang; H Liang; P Li; H J Xiao; J Ji; W Xiang; J F Shi; Y G Fan; L Li; D Wang; S S Deng; W Q Chen; W Q Wei; Y L Qiao; P Boffetta Journal: Ann Oncol Date: 2012-06-11 Impact factor: 32.976
Authors: Susan J Jordan; Louise F Wilson; Christina M Nagle; Adele C Green; Catherine M Olsen; Christopher J Bain; Nirmala Pandeya; David C Whiteman; Penelope M Webb Journal: Aust N Z J Public Health Date: 2015-10 Impact factor: 2.939